Literature DB >> 19349320

Statin adherence and risk of accidents: a cautionary tale.

Colin R Dormuth1, Amanda R Patrick, William H Shrank, James M Wright, Robert J Glynn, Jenny Sutherland, M Alan Brookhart.   

Abstract

BACKGROUND: Bias in studies of preventive medications can occur when healthier patients are more likely to initiate and adhere to therapy than less healthy patients. We sought evidence of this bias by examining associations between statin exposure and various outcomes that should not be causally affected by statin exposure, such as workplace and motor vehicle accidents. METHODS AND
RESULTS: We conducted a prospective cohort study of statin patients using data from British Columbia, Canada, a multiethnic society with a population of 4.3 million people. Study subjects were 141 086 patients who initiated statins for primary prevention. We examined the association between adherence and multiple outcomes such as accidents and screening procedures using multivariable-adjusted Cox proportional hazards models. The study population was 49% female and had an average age of 61 years. The results from our multivariable-adjusted models showed that more adherent patients were less likely to have accidents than less adherent patients. This effect was greatest for motor vehicle accidents (hazard ratio, 0.75; 95% confidence interval, 0.72 to 0.79) and workplace accidents (hazard ratio, 0.77; 95% confidence interval, 0.74 to 0.81). More adherent patients had a greater likelihood of using screening services (hazard ratio, 1.17; 95% confidence interval, 1.15 to 1.20) and a lower likelihood of developing other diseases likely to be unrelated to a biological affect of a statin (hazard ratio, 0.87; 95% confidence interval, 0.86 to 0.89).
CONCLUSIONS: Our study contributes compelling evidence that patients who adhere to statins are systematically more health seeking than comparable patients who do not remain adherent. Caution is warranted when interpreting analyses that attribute surprising protective effects to preventive medications.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19349320      PMCID: PMC2744446          DOI: 10.1161/CIRCULATIONAHA.108.824151

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  29 in total

1.  Evidence of bias in estimates of influenza vaccine effectiveness in seniors.

Authors:  Lisa A Jackson; Michael L Jackson; Jennifer C Nelson; Kathleen M Neuzil; Noel S Weiss
Journal:  Int J Epidemiol       Date:  2005-12-20       Impact factor: 7.196

Review 2.  A meta-analysis of the association between adherence to drug therapy and mortality.

Authors:  Scot H Simpson; Dean T Eurich; Sumit R Majumdar; Rajdeep S Padwal; Ross T Tsuyuki; Janice Varney; Jeffrey A Johnson
Journal:  BMJ       Date:  2006-06-21

3.  Statins and the risk of lung, breast, and colorectal cancer in the elderly.

Authors:  Soko Setoguchi; Robert J Glynn; Jerry Avorn; Helen Mogun; Sebastian Schneeweiss
Journal:  Circulation       Date:  2006-12-18       Impact factor: 29.690

4.  Hormone replacement therapy, heart disease, and other considerations.

Authors:  E Barrett-Connor; D Grady
Journal:  Annu Rev Public Health       Date:  1998       Impact factor: 21.981

5.  Selective prescribing led to overestimation of the benefits of lipid-lowering drugs.

Authors:  Robert J Glynn; Sebastian Schneeweiss; Philip S Wang; Raia Levin; Jerry Avorn
Journal:  J Clin Epidemiol       Date:  2006-05-26       Impact factor: 6.437

Review 6.  Hormone replacement therapy and acute coronary outcomes: methodological issues between randomized and observational studies.

Authors:  E Garbe; S Suissa
Journal:  Hum Reprod       Date:  2004-01       Impact factor: 6.918

7.  Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.

Authors:  J R Downs; M Clearfield; S Weis; E Whitney; D R Shapiro; P A Beere; A Langendorfer; E A Stein; W Kruyer; A M Gotto
Journal:  JAMA       Date:  1998-05-27       Impact factor: 56.272

8.  The impact of the use of statins on the prevalence of dementia and the progression of cognitive impairment.

Authors:  Ihab Hajjar; Jeannie Schumpert; Victor Hirth; Darryl Wieland; G Paul Eleazer
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2002-07       Impact factor: 6.053

9.  Life long changes in cognitive ability are associated with prescribed medications in old age.

Authors:  John M Starr; Brian McGurn; Martha Whiteman; Alison Pattie; Lawrence J Whalley; Ian J Deary
Journal:  Int J Geriatr Psychiatry       Date:  2004-04       Impact factor: 3.485

10.  Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group.

Authors:  J Shepherd; S M Cobbe; I Ford; C G Isles; A R Lorimer; P W MacFarlane; J H McKillop; C J Packard
Journal:  N Engl J Med       Date:  1995-11-16       Impact factor: 91.245

View more
  90 in total

1.  Adherence to osteoporosis drugs and fracture prevention: no evidence of healthy adherer bias in a frail cohort of seniors.

Authors:  S M Cadarette; D H Solomon; J N Katz; A R Patrick; M A Brookhart
Journal:  Osteoporos Int       Date:  2010-06-08       Impact factor: 4.507

2.  Understanding the potential role of statins in pneumonia and sepsis.

Authors:  Sachin Yende; Eric B Milbrandt; John A Kellum; Lan Kong; Russell L Delude; Lisa A Weissfeld; Derek C Angus
Journal:  Crit Care Med       Date:  2011-08       Impact factor: 7.598

3.  Does medication adherence itself confer fracture protection? An investigation of the healthy adherer effect in observational data.

Authors:  Jeffrey R Curtis; Huifeng Yun; Jeff L Lange; Robert Matthews; Pradeep Sharma; Kenneth G Saag; Elizabeth Delzell
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-12       Impact factor: 4.794

Review 4.  Healthy user and related biases in observational studies of preventive interventions: a primer for physicians.

Authors:  William H Shrank; Amanda R Patrick; M Alan Brookhart
Journal:  J Gen Intern Med       Date:  2011-01-04       Impact factor: 5.128

5.  Counterpoint: the treatment decision design.

Authors:  M Alan Brookhart
Journal:  Am J Epidemiol       Date:  2015-10-26       Impact factor: 4.897

6.  Propensity score methods for confounding control in nonexperimental research.

Authors:  M Alan Brookhart; Richard Wyss; J Bradley Layton; Til Stürmer
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2013-09-10

7.  Confounding control in healthcare database research: challenges and potential approaches.

Authors:  M Alan Brookhart; Til Stürmer; Robert J Glynn; Jeremy Rassen; Sebastian Schneeweiss
Journal:  Med Care       Date:  2010-06       Impact factor: 2.983

8.  Lipid lowering: education is key.

Authors:  Valentin Fuster; Bryony M Mearns
Journal:  Nat Rev Cardiol       Date:  2009-10       Impact factor: 32.419

9.  The effect of statin therapy on the incidence of infections: a retrospective cohort analysis.

Authors:  John P Magulick; Christopher R Frei; Sayed K Ali; Eric M Mortensen; Mary Jo Pugh; Christine U Oramasionwu; Kelly R Daniels; Ishak A Mansi
Journal:  Am J Med Sci       Date:  2014-03       Impact factor: 2.378

10.  Statin potency and the risk of hospitalization for community-acquired pneumonia.

Authors:  Ju-Young Shin; Maria Eberg; Pierre Ernst; Kristian B Filion
Journal:  Br J Clin Pharmacol       Date:  2017-01-29       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.